Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

The Ongoing Challenges of Managing Cytopenic Myelofibrosis in 2025: The Emergence of Non-JAK Inhibitor Therapies

Saved in:
Bibliographic Details
Published in:Blood and Lymphatic Cancer : Targets and Therapy
Format: Online Article RSS Article
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301672977432576
collection WordPress RSS
FRELIP Feed Integration
container_title Blood and Lymphatic Cancer : Targets and Therapy
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:61067
institution FRELIP
journal_source_facet Blood and Lymphatic Cancer : Targets and Therapy
publishDate 2025
publishDateSort 2025
record_format rss_article
spellingShingle The Ongoing Challenges of Managing Cytopenic Myelofibrosis in 2025: The Emergence of Non-JAK Inhibitor Therapies
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title The Ongoing Challenges of Managing Cytopenic Myelofibrosis in 2025: The Emergence of Non-JAK Inhibitor Therapies
title_auth The Ongoing Challenges of Managing Cytopenic Myelofibrosis in 2025: The Emergence of Non-JAK Inhibitor Therapies
title_full The Ongoing Challenges of Managing Cytopenic Myelofibrosis in 2025: The Emergence of Non-JAK Inhibitor Therapies
title_fullStr The Ongoing Challenges of Managing Cytopenic Myelofibrosis in 2025: The Emergence of Non-JAK Inhibitor Therapies
title_full_unstemmed The Ongoing Challenges of Managing Cytopenic Myelofibrosis in 2025: The Emergence of Non-JAK Inhibitor Therapies
title_short The Ongoing Challenges of Managing Cytopenic Myelofibrosis in 2025: The Emergence of Non-JAK Inhibitor Therapies
title_sort the ongoing challenges of managing cytopenic myelofibrosis in 2025: the emergence of non-jak inhibitor therapies
topic Oncology
General
Oncology
url https://www.dovepress.com/the-ongoing-challenges-of-managing-cytopenic-myelofibrosis-in-2025-the-peer-reviewed-fulltext-article-BLCTT